A group of lawmakers spanning both parties and chambers is introducing legislation that would require insurance plans to cover genetic testing for patients with hereditary risk factors and expand education and outreach about gynecologic cancer risk. Sens. Elissa Slotkin (D-Mich.) and Katie Britt (R-Ala.) are leading the bill, the Ovarian Cancer IMPACT Act, which was...
President Donald Trump regularly defends his administration's record by contrasting it favorably with the Biden era, or other blaming the former president.
President Donald Trump regularly defends his administration's record by contrasting it favorably with the Biden era, or other blaming the former president.
After last year's successful $10 billion sale of Metsera, then launching an inflammatory disease biotech earlier this year, ARCH Venture Partners and Population Health Partners have teamed up again…
It will be Clancy's first return to the courthouse since her first trial ended Sept. 4 with a deadlocked jury. A judge declared a mistrial with the jury split 11 to 1 in favor of acquitting Clancy of…
This marks Anupam Rasayan’s third strategic inorganic transaction, as the Surat-based specialty chemicals maker expands into finished pharmaceutical formulations
